An Israeli startup that opened a St. Louis office last year has agreed a licensing deal with Monsanto, giving the Creve Coeur-based seed company access to its algorithms for gene and trait research.
NRGene, which operates out of the Cortex innovation district, develops data analysis tools to help plant researchers. Monsanto and NRGene on Thursday announced a multi-year, nonexclusive license of its GenoMAGIC platform. Financial details weren’t disclosed.
Monsanto is licensing the startup’s genome-analysis technology to better predict, compare and select the genetic makeup from its data sets of genetic, genomic and trait information.